NASDAQ:QNRX | Cash Flow Statement | Quoin Pharmaceuticals, Ltd.

Complete source-backed cash-flow history.

Available history
2019-12-31 to 2026-06-30
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-06-30-$5.37M
2026-03-31-$5M-$4.87M$4.12M$55,982.00
2025-12-31-$4.35M-$5.04M-$11.27M$18.29M
2025-09-30-$3.95M
2025-06-30-$3.7M
2025-03-31-$3.81M-$2.59M$2.77M$22,958.00
2024-12-31-$2.31M-$2.24M-$3.18M$5.92M
2024-09-30-$2.35M
2024-06-30-$1.97M
2024-03-31-$2.33M-$1.43M-$4.47M$5.33M
2023-12-31-$2.05M-$3.22M$2.64M-$182,583.00
2023-09-30-$1.93M
2023-06-30-$2.11M
2023-03-31-$2.6M-$1.75M-$3.49M$5.75M
2022-12-31-$2M-$1.94M$0.00-$446,862.00
2022-09-30-$3.03M
2022-06-30-$2.67M
2022-03-31-$1.68M-$2.09M-$50,000.00-$150,000.00
2021-12-31-$11.82M-$3.18M-$250,000.00$10.26M
2021-09-30-$1.4M
2021-06-30-$4.34M
2021-03-31-$3.9M

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-12-31-$15.8M-$13.54M-$4.28M$18.01M
2024-12-31-$8.96M-$7.86M-$1.89M$10.97M
2023-12-31-$8.69M-$7.86M$2.19M$5.22M
2022-12-31-$9.38M-$8.48M-$10.15M$14.01M
2021-12-31-$21.46M-$5.72M-$625,000.00$13.5M
2020-12-31-$2.1M-$1.34M-$125,000.00$1.79M
2019-12-31-$1.56M-$1.3M$1.3M

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.